LSBio
CHEK1 / CHK1 Antibody (phospho-Ser345)

Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using Chk1 (Phospho-Ser345) Antibody. The picture on the right is blocked with the phospho peptide.

CHEK1 / CHK1 Antibody (phospho-Ser345)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human, Mouse, Rat
Format:Liquid
See all Human CHEK1 / CHK1 antibodies →
$341.00each
Catalog Number: LS-C117319-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
CHK1 antibody LS-C117319 is an unconjugated rabbit polyclonal antibody to CHK1 (CHEK1) (pSer345) from human. It is reactive with human, mouse and rat. Validated for IHC and Peptide-ELISA. Cited in 1 publication.
Application
ELISA, IHC, IHC-P, WB
Reactivity
Hu, Ms, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
CHEK1 | CHK1 checkpoint homolog | Cell cycle checkpoint kinase | Checkpoint kinase 1 | CHK1 | Chk1-S | Protein kinase chk1 | Checkpoint kinase-1
UniProt Number
O14757
SwissProt
O14757

Target

Target
Human CHEK1 / CHK1
Antigen Species
Human
Epitope
Chk1 (Phospho-Ser345) Antibody detects endogenous levels of Chk1 only when phosphorylated at serine345.
Gene Name
CHEK1

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
Synthetic peptide from human Chk1 around the phosphorylation site of Ser345. (AA Range: 310-359)
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS (without Mg2+, Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide, 50% Glycerol
Concentration
1 mg/mL
Volume
50 Microliter
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C for up to 1 year.
Recommended Storage Buffer
PBS|150 mM NaCl
Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro. Wang Z, Førsund MS, Trope CG, Nesland JM, Holm R, Slipicevic A. Cancer medicine. 2018 August;7:3955-3964. PubMed: 29963769 PMC: PMC6089182

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.